Mackenzie Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,019
Closed -$210K 1492
2025
Q4
$210K Buy
+9,019
New +$201K ﹤0.01% 1527
2025
Q2
Sell
-40,288
Closed -$977K 1730
2025
Q1
$977K Buy
40,288
+5,757
+17% +$130K ﹤0.01% 990
2024
Q4
$721K Buy
34,531
+19,705
+133% +$423K ﹤0.01% 1029
2024
Q3
$295K Buy
14,826
+810
+6% +$15K ﹤0.01% 1197
2024
Q2
$217K Buy
+14,016
New +$218K ﹤0.01% 1313
2022
Q4
Sell
-55,512
Closed -$712K 1466
2022
Q3
$712K Sell
55,512
-476
-0.9% -$5.64K ﹤0.01% 868
2022
Q2
$392K Buy
55,988
+1,292
+2% +$9.48K ﹤0.01% 995
2022
Q1
$453K Sell
54,696
-23,922
-30% -$169K ﹤0.01% 1005
2021
Q4
$532K Buy
+78,618
New +$517K ﹤0.01% 991
2020
Q4
Sell
-10,900
Closed -$32K 1052
2020
Q3
$32K Buy
+10,900
New +$42.6K ﹤0.01% 974

Other funds holding CPRX